03 February 2026 : Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation
Byeong-Gon Na
BCE 1, Shin Hwang ABCDEF 1*, Jinil Han BCD 2, Dong-Hwan Jung BCD 1, Gi-Won Song BCD 1, Yun Young Lee BCD 2, Eunyoung Tak BCD 3, Kyoung-Jin Lee BCD 3, Yun-Kyu Kim BCD 3
DOI: 10.12659/AOT.951568
Ann Transplant 2026; 31:e951568
Figure 1 Comparison of FAR1 methylation (A), α-fetoprotein (AFP; B) and protein induced by vitamin K absence or antagonist-II (PIVKA-II; C) levels in the hepatocellular carcinoma (HCC) study, non-HCC cirrhotic liver, and normal-liver control groups.